Abbvie Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Great. Good morning, everybody. I'm Terence Flynn, the biopharma analyst at Goldman Sachs. I'm very pleased to be hosting AbbVie this morning. Joining us from the company, we have Rick Gonzalez, Chairman and CEO; Mike Severino, Vice Chairman and President; and Rob Michael, Executive VP and CFO of the company.
Thank you very much for spending time today with us, everyone, and really appreciate it.
Questions & Answers
Maybe just to get started at a high level. Obviously, COVID is top of mind for everyone. And in our view, it's going to have near and long-lasting impacts on the health care system and business models if you think about delivery of care, clinical trial conduct and supply chain. So Rick, was just wondering, maybe to start, if you could share any preliminary perspective from where you sit on the ways COVID could shape your business and strategy?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |